Boot (Henry) plc Half-Year Report
GSK plc- Apretude for PrEP Receives EMA Approval
Concurrent Technologies plc Interim Results for Six Months Ended 30th June 2023
Renishaw plc Preliminary Results for Year Ended 30th June 2023
B.P.Marsh & Partners plc Trading Update for the Six Months to 31st July 2023
GSK Announces Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia
AMS signs agreement with TELA Bio, Inc. to commercialise LiquiBand Fix8® in the US under the brand name LIQUIFIXâ„¢
